Esperto Medical

• 21/02/2025
• Series A
• Undisclosed Amount

Bringing data driven medicine to the masses.

I am the Founder and member of the Board of Directors of ChromaCode, a cutting-edge software and reagent technology company that uses digital signal processing to dramatically improve clinical molecular analysis.

I'm also the CEO of Esperto Medical, a venture backed Caltech spin-out focused on replacing arterial catheters with a continuous, yet non-invasive, blood pressure device.

In my academic life, I am part-time faculty at Caltech and USC, where I work on novel medical imaging hardware, digital signal processing, nano-scale electronics, low-power circuits for implantable sensor systems.

---

---